InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

- Current share price for DXB : $0.235

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$141 First Patient Reaches Four Years in DMX-200 Clinical Program 5 Oct 2026 8:56AM $0.225 $0.235 risen by 4.44%
$141 Notification regarding unquoted securities - DXB 28 Sep 2026 2:34PM $0.228 $0.235 risen by 3.30%
$141 Notification of 2026 Annual General Meeting Date 25 Sep 2026 2:42PM $0.230 $0.235 risen by 2.17%
$141 Dimerix Presents at ASX SMIDcaps Conference 2026 23 Sep 2026 8:44AM $0.240 $0.235 fallen by 2.08%
$141 Dimerix Draws Down A$17M Under Non-Dilutive Funding Facility 23 Sep 2026 8:36AM $0.240 $0.235 fallen by 2.08%
$141 Waiver of Listing Rule 10.1 Granted 22 Sep 2026 3:46PM $0.240 $0.235 fallen by 2.08%
$141 Dimerix Presents at E&P Healthcare Conference 2026 16 Sep 2026 8:31AM $0.235 $0.235 fallen by 0%
$141 Dimerix DMX-652 Granted Mexican Composition of Matter Patent 14 Sep 2026 8:39AM $0.250 $0.235 fallen by 6%
$141 Dimerix Investor Presentation 7 Sep 2026 8:51AM $0.285 $0.235 fallen by 17.54%
$141 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $0.285 $0.235 fallen by 17.54%
$141 Dimerix Secures A$34 Million Non-Dilutive Funding Facility 4 Sep 2026 9:17AM $0.290 $0.235 fallen by 18.97%
$141 Trading Halt 2 Sep 2026 8:43AM $0.290 $0.235 fallen by 18.97%
$141 Appendix 4G and Corporate Governance Statement 27 Aug 2026 8:56AM $0.290 $0.235 fallen by 18.97%
$141 Appendix 4E and 2026 Annual Report 27 Aug 2026 8:56AM $0.290 $0.235 fallen by 18.97%
$141 Dimerix Receives US$10M Upfront Payment from Everest 20 Aug 2026 9:13AM $0.295 $0.235 fallen by 20.34%
$141 Dimerix Assumes Sponsorship of US IND for New Asset DMX-652 17 Aug 2026 8:38AM $0.295 $0.235 fallen by 20.34%
$141 Dimerix Presents at Bioshares Summit 2026 6 Aug 2026 8:17AM $0.290 $0.235 fallen by 18.97%
$141 Dimerix Quarterly Activities Report and Appendix 4C 30 Jul 2026 8:49AM $0.240 $0.235 fallen by 2.08%
$141 Dimerix to Present at TechKnow Invest Conference 2026 27 Jul 2026 8:36AM $0.250 $0.235 fallen by 6%
$141 US Patent Granted for Dimerix New Asset DMX-652 23 Jul 2026 8:46AM $0.250 $0.235 fallen by 6%
$141 Dimerix Investor Webinar 17 Jul 2026 9:03AM $0.240 $0.235 fallen by 2.08%
$141 Dimerix Expands Pipeline with Acquisition of Phase 2 Asset 17 Jul 2026 9:03AM $0.240 $0.235 fallen by 2.08%
$141 Dimerix Non-Dilutive Funding Builds Pipeline, Boosts Runway 17 Jul 2026 9:01AM $0.240 $0.235 fallen by 2.08%
$141 Trading Halt 15 Jul 2026 8:42AM $0.240 $0.235 fallen by 2.08%
$141 DMX-200 Available To Patients Via Post-Trial Access Pathways 9 Jul 2026 8:46AM $0.240 $0.235 fallen by 2.08%

1 - 25 of 739 results

Page 1 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.